Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AZD9898 is an inhibitor of leukotriene-C4 synthetase with an IC50 of 0.28 nM. AZD9898 can be used in studies about asthma. AZD9898 mitigates the GABA binding and hepatic toxicity signal.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 233.00 | |
5 mg | In stock | $ 587.00 | |
10 mg | In stock | $ 839.00 | |
25 mg | In stock | $ 1,280.00 | |
50 mg | In stock | $ 1,720.00 |
Description | AZD9898 is an inhibitor of leukotriene-C4 synthetase with an IC50 of 0.28 nM. AZD9898 can be used in studies about asthma. AZD9898 mitigates the GABA binding and hepatic toxicity signal. |
Targets&IC50 | LTC4S:0.28 nM |
In vivo | AZD9898 (10 and 100 mg/kg; oral) is well tolerated and shows no safety concerns[1]. |
Molecular Weight | 457.83 |
Formula | C20H19ClF3N3O4 |
CAS No. | 2042347-69-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 225mg/mL (491.4mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AZD9898 2042347-69-1 GPCR/G Protein Leukotriene Receptor AZD-9898 AZD 9898 inhibitor inhibit